CVS vs TRDA · P/E 16, rev $402.07B vs P/E 12, rev $210.8M
CVS Health Corp (CVS) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the CVS and TRDA stock pages for the full models.
Not investment advice.